REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,108,360 | -55.3% | 4,630,197 | -1.4% | 0.01% | -53.8% |
| Q2 2023 | $118,802,305 | -28.6% | 4,693,888 | -9.1% | 0.01% | -35.0% |
| Q1 2023 | $166,338,000 | +179594.7% | 5,164,157 | +3.0% | 0.02% | +66.7% |
| Q4 2022 | $92,567 | -99.9% | 5,014,422 | -8.0% | 0.01% | -42.9% |
| Q3 2022 | $147,163,000 | +59.2% | 5,450,498 | -18.5% | 0.02% | +61.5% |
| Q2 2022 | $92,427,000 | -30.5% | 6,687,925 | -1.9% | 0.01% | -18.8% |
| Q1 2022 | $132,937,000 | +17.6% | 6,817,205 | -1.6% | 0.02% | +23.1% |
| Q4 2021 | $113,038,000 | -20.2% | 6,926,406 | +36.3% | 0.01% | -27.8% |
| Q3 2021 | $141,593,000 | -5.3% | 5,082,305 | +0.8% | 0.02% | 0.0% |
| Q2 2021 | $149,490,000 | +20.6% | 5,043,571 | +13.8% | 0.02% | +5.9% |
| Q1 2021 | $123,926,000 | +1.1% | 4,433,826 | +2.5% | 0.02% | -5.6% |
| Q4 2020 | $122,600,000 | +16.9% | 4,326,053 | +6.1% | 0.02% | 0.0% |
| Q3 2020 | $104,871,000 | +6.6% | 4,079,056 | +1.3% | 0.02% | -5.3% |
| Q2 2020 | $98,358,000 | +69.8% | 4,027,774 | +2.9% | 0.02% | +35.7% |
| Q1 2020 | $57,936,000 | -11.3% | 3,914,598 | -2.7% | 0.01% | +16.7% |
| Q4 2019 | $65,311,000 | +89.2% | 4,024,157 | +51.6% | 0.01% | +71.4% |
| Q3 2019 | $34,512,000 | +10.4% | 2,654,772 | +7.3% | 0.01% | +16.7% |
| Q2 2019 | $31,259,000 | -49.1% | 2,474,903 | -36.5% | 0.01% | -53.8% |
| Q1 2019 | $61,431,000 | -19.8% | 3,897,870 | +2.4% | 0.01% | -27.8% |
| Q4 2018 | $76,596,000 | -15.5% | 3,805,059 | +4.3% | 0.02% | +5.9% |
| Q3 2018 | $90,617,000 | -9.9% | 3,646,611 | -0.5% | 0.02% | -19.0% |
| Q2 2018 | $100,617,000 | -5.0% | 3,665,447 | +6.6% | 0.02% | -8.7% |
| Q1 2018 | $105,872,000 | -16.8% | 3,437,417 | -3.4% | 0.02% | -14.8% |
| Q4 2017 | $127,198,000 | +31.6% | 3,557,979 | +0.3% | 0.03% | +28.6% |
| Q3 2017 | $96,635,000 | +0.9% | 3,546,267 | -2.2% | 0.02% | -4.5% |
| Q2 2017 | $95,743,000 | +33.0% | 3,626,603 | +4.8% | 0.02% | +37.5% |
| Q1 2017 | $71,965,000 | +1.4% | 3,459,844 | +0.9% | 0.02% | -5.9% |
| Q4 2016 | $71,004,000 | +34.0% | 3,430,158 | +5.0% | 0.02% | +30.8% |
| Q3 2016 | $52,969,000 | +17.1% | 3,267,701 | -1.8% | 0.01% | +18.2% |
| Q2 2016 | $45,247,000 | -14.4% | 3,327,022 | +9.9% | 0.01% | -21.4% |
| Q1 2016 | $52,879,000 | -47.2% | 3,028,574 | +3.2% | 0.01% | -44.0% |
| Q4 2015 | $100,231,000 | +141.5% | 2,934,142 | +110.4% | 0.02% | +127.3% |
| Q3 2015 | $41,509,000 | -7.1% | 1,394,779 | -0.1% | 0.01% | 0.0% |
| Q2 2015 | $44,661,000 | +75.9% | 1,396,505 | +14.0% | 0.01% | +83.3% |
| Q1 2015 | $25,385,000 | +107.5% | 1,224,563 | +69.5% | 0.01% | +100.0% |
| Q4 2014 | $12,236,000 | -20.0% | 722,276 | -8.7% | 0.00% | -25.0% |
| Q3 2014 | $15,287,000 | -33.4% | 790,817 | +17.1% | 0.00% | -33.3% |
| Q2 2014 | $22,969,000 | +170.9% | 675,598 | +151.0% | 0.01% | +200.0% |
| Q1 2014 | $8,480,000 | – | 269,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $20,260,000 | 52.86% |
| Essex Woodlands Management, Inc. | 3,342,047 | $43,447,000 | 27.06% |
| Sio Capital Management, LLC | 305,664 | $3,974,000 | 1.28% |
| Fosun International Ltd | 472,532 | $6,143,000 | 0.68% |
| ArrowMark Colorado Holdings LLC | 4,831,653 | $62,811,000 | 0.63% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,078,697 | $14,023,000 | 0.50% |
| Rhenman & Partners Asset Management AB | 173,917 | $2,261,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 26,365 | $343,000 | 0.14% |
| FIRST MIDWEST BANK TRUST DIVISION | 67,141 | $873,000 | 0.13% |
| Rock Creek Group, LP | 18,500 | $241,000 | 0.12% |